BridgeMD
New treatment option for Undifferentiated Connective Tissue Diseases
Official title Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease
ClinicalTrials.gov ID: NCT06399822
What this study is testing
- What it's testing
- Connective tissue diseases (CTD) are a group of diseases with diverse manifestations, most often multisystemic, which share an autoimmune etiology. They include Systemic lupus erythematosus (SLE), Systemic sclerosis (SSc), Sjögren's syndrome (SS), Inflammatory myopathies (IM) and Mixed connective tissue disease (MCTD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Be aged 18 and over;
- Have been diagnosed with undifferentiated connective tissue disease by a rheumatologist;
- Meet the preliminary classification criteria for undifferentiated connective tissue disease: present signs and symptoms suggestive of connective...
- Have developed the first signs and symptoms of the disease less than 10 years before recruitment.
You likely can't join if
- In the opinion of the clinician, have a health condition that does not allow a delay of six months before carrying out the capillaroscopy;
- Have been diagnosed and/or meet the classification criteria for another connective tissue disease (for example, systemic lupus, etc.);
- Have already performed a capillaroscopy in the past, regardless of the time or the reason;
- Be unable to consent or respond to questionnaires.
The study team makes the final eligibility decision.
Where it's taking place
- Québec, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Québec, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.